CLINICAL_TRIALS
research
· 2025-08-06
Clinical Trial Update: Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC [NA]
Summary
This study analyzes the biological characteristics of advanced ALK-rearranged non-small cell lung cancer. It is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Groupe Francais De Pneumo-Cancerologie | Conditions: Non-small Cell Lung Cancer, ALK Gene Rearrangement Positive | NA | Status: RECRUITING